Scientists hunt for hidden cancer cells that survive targeted therapy
NCT ID NCT04222335
First seen May 03, 2026 · Last updated Jun 10, 2026 · Updated 8 times
Summary
This study looks at why lung cancer cells become resistant to a targeted drug called osimertinib. Researchers will collect blood and tissue samples from 80 patients to study these resistant cells. The goal is to find new ways to prevent the cancer from coming back.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER, NONSMALL CELL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Toulouse University Hospital
Toulouse, Occitanie, 31300, France
Conditions
Explore the condition pages connected to this study.